Polydipsia

Revision as of 21:19, 25 January 2009 by Johnfanisrour (talk | contribs)
Jump to navigation Jump to search
Polydipsia
ICD-10 R63.1
ICD-9 783.5

WikiDoc Resources for Polydipsia

Articles

Most recent articles on Polydipsia

Most cited articles on Polydipsia

Review articles on Polydipsia

Articles on Polydipsia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Polydipsia

Images of Polydipsia

Photos of Polydipsia

Podcasts & MP3s on Polydipsia

Videos on Polydipsia

Evidence Based Medicine

Cochrane Collaboration on Polydipsia

Bandolier on Polydipsia

TRIP on Polydipsia

Clinical Trials

Ongoing Trials on Polydipsia at Clinical Trials.gov

Trial results on Polydipsia

Clinical Trials on Polydipsia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Polydipsia

NICE Guidance on Polydipsia

NHS PRODIGY Guidance

FDA on Polydipsia

CDC on Polydipsia

Books

Books on Polydipsia

News

Polydipsia in the news

Be alerted to news on Polydipsia

News trends on Polydipsia

Commentary

Blogs on Polydipsia

Definitions

Definitions of Polydipsia

Patient Resources / Community

Patient resources on Polydipsia

Discussion groups on Polydipsia

Patient Handouts on Polydipsia

Directions to Hospitals Treating Polydipsia

Risk calculators and risk factors for Polydipsia

Healthcare Provider Resources

Symptoms of Polydipsia

Causes & Risk Factors for Polydipsia

Diagnostic studies for Polydipsia

Treatment of Polydipsia

Continuing Medical Education (CME)

CME Programs on Polydipsia

International

Polydipsia en Espanol

Polydipsia en Francais

Business

Polydipsia in the Marketplace

Patents on Polydipsia

Experimental / Informatics

List of terms related to Polydipsia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: John Fani Srour, M.D.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Polydipsia is a medical condition in which the patient ingests abnormally large amounts of fluids by mouth. The word is made from the words poly meaning many and dipsia which means thirst. The fluid is usually water, though some people may think of alcohol because of the etymologically related term dipsomaniac, meaning an alcoholic.

Differential diagnosis of the causes of polydipsia

Common causes

Polydipsia is almost always associated with dehydration due to polyuria (excessive urination), if the condition is prolonged beyond a few hours in those with functioning kidneys.

It is often, and characteristically, found in diabetics, often as one of the initial symptoms, and in those who fail to take their anti-diabetic medications or whose dosages have become inadequate. It is also caused by other conditions featuring osmotic diuresis and by diabetes insipidus ("water diabetes"), and forms part of the differential diagnostic tree for them, as well. Polydipsia is also a symptom of atropine or belladonna poisoning. Another cause can be due to medication (such as diuretics) or inadvertent consumption of caffeine. One who drinks nothing but coffee or soda can be easily misdiagnosed by a medical professional as psychogenic polydipsia, as they may be unaware they are consuming diuretics.

Complete differential diagnosis of causes of polydipsia

(In alphabetical order)

Complete differential diagnosis of the causes of polydipsia

(By organ system)

Cardiovascular Arteriovenous malformations or aneurysms (vascular)
Chemical / poisoning belladonna poisoning,
Dermatologic No underlying causes
Drug Side Effect Bendrofluazide, Bumetanide, Conivaptan, Frusemide,Hydrochlorothiazide, Lithium, Vasopressin, atropine, belladonna poisoning, caffeine, Amikacin, Amphotericin B,Demeclocycline, Gentamicin
Ear Nose Throat No underlying causes
Endocrine Cushing syndrome, Primary hyperparathyroidism, Hyperglycemia

Diabetes insipidus, Water intoxication, Hyperthyroidism, Maturity onset diabetes of the young, Diabetes mellitus, Antidiuretic Hormone

Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic Polycystic kidney disease(autosomal dominant), Congenital nephrogenicDiabetes insipidus, Bardet-Biedl syndrome, Sickle cell disease, DIDMOAD syndrome, Fanconi syndrome
Hematologic Sickle cell disease
Iatrogenic Radiation therapy
Infectious Disease meningoencephalitis, Syphilis, Tuberculosis, Meningitis, Cysticercosis (cerebral), Post encephalitis status, Tuberculoma of the hypothalamus
Musculoskeletal / Ortho No underlying causes
Neurologic Craniopharyngioma, Pineal tumors, Hypoxic encephalopathy, Pituitary tumour, Metastatic brain disease, Meningioma, Hydrocephalus, (obstructive)
Nutritional / Metabolic No underlying causes
Obstetric/Gynecologic Gestational diabetes insipidus, Sheehan syndrome
Oncologic pineal tumors, Craniopharyngioma, Histiocytosis X,Pituitary tumour, Leukemia(acute), Metastatic brain disease, Meningioma
Opthalmologic No underlying causes
Overdose / Toxicity Beer potomania, Water intoxication
Psychiatric Psychogenic polydipsia, Beer potomania
Pulmonary No underlying causes
Renal / Electrolyte Bardet-Biedl syndrome,Bartter syndrome,Cystinosis, Congenital nephrogenicDiabetes insipidus, Hypercalcaemia, Hypokalaemia, Interstitial nephritis, Loken Senior syndrome, Medullary cystic renal disease, Polycystic kidney disease(autosomal dominant), Proximal renal tubular acidosis,Pyelonephritis,Renal failure, Urinary tract infection
Rheum / Immune / Allergy Sarcoidosis, Amyloidosis
Sexual No underlying causes
Trauma Head trauma, Skull fracture
Urologic No underlying causes
Miscellaneous Sarcoidosis, Histiocytosis X

Polydipsia in Psychiatric Subsets

Psychogenic polydipsia is a type of polydypsia with described in patients with mental illnesses and/or the developmentally disabled. It is present in a subset of schizophrenics. These patients, most often chronic schizophrenics with a long history of illness, often exhibit enlarged ventricles and shrunken cortex on MRI, making the physiological mechanism difficult to isolate from the psychogenic. It is a serious disorder and often leads to institutionalization as it can be very difficult to manage outside the inpatient setting. It should be taken very seriously - it can be life threatening as serum sodium is diluted to an extent that seizures and cardiac arrest can occur. Patients have been known to seek fluids from any source possible.

In treatment resistant polydipsic psychiatric patients, regulation in the inpatient milieau can be accomplished by use of a weight-water protocol. First, baseline weights must be established and correlated to serum sodium levels. Weight will normally fluctuate during the day, but as the water intake of the polydipsic goes up, the weight will naturally rise. The physician can order a stepped series of interventions as the weight rises. The correlation must be individualized with attention paid to the patient's normal weight and fluctuations, diet, co-morbid disorders (such as a seizure disorder) and urinary system functioning. Progressive steps might include redirection, room restriction, and increasing levels of physical restraint with monitoring. Such plans should also progressive increases in monitoring, as well as a level at which a serum sodium level is drawn.

It is important to note that the majority of psychotropic drugs (as well as many of other classes) can cause dry mouth, but this is not to be confused with true polydipsia in which a dangerous drop in serum sodium will be seen.

While psychogenic polydipsia is generally not found outside the population of those with serious mental disorders, there is some anecdotal evidence of a milder form (typically called 'habit polydispsia' or 'habit drinking') that can occasionally be found in the absence of psychosis or other mental conditions. The excessive levels of fluid intake may result in a false diagnosis of diabetes insipidus, since the chronic ingestion of excessive water can produce diagnostic results that closely mimic those of mild diabetes insipidus.

Diagnosis

Polydipsia is a symptom, not a disease (cause). To diagnose the cause of polydipsia a fluid deprivation test is used, which may require a patient to abstain from water, and for blood and urine tests to be undertaken. Additional blood work may be required to test for the presence of diuretics, such as caffeine, or recreational drugs. Finally neurological testing may be required to determine if there has been damage to the hypothalamus ( central diabetes insipidus). These tests are routinally used in diagnosing diabetes insipidus.

Treatment

Most patients with diabetes insipidus (DI) can drink enough fluid to replace their urine losses. Losses can also be replaced with dextrose and water or IV fluid hyposmolar to the patient's serum. During replacement, avoid volume overload and a correction of hypernatremia that is too rapid. A good rule of thumb is to reduce serum sodium by 0.5 mmol/L/h. Water deficit may be calculated based on the assumption that body water is approximately 60% of body weight in kilograms. In case of inadequate thirst, desmopressin is the drug of choice. Generally, it can be administered 2-3 times per day. Patients may require hospitalization to establish fluid needs. Frequent electrolyte monitoring is recommended. Vasopressin or desmopressin acetate, modified synthetic forms of antidiuretic hormone, may be taken as a nasal spray several times a day, to maintain a normal urine output. However, taking too much of this medication can cause fluid retention and swelling and other problems. Sometimes diabetes insipidus can be controlled with drugs that stimulate production of antidiuretic hormone such as chlorpropamide, carbamazepine, clofibrate. If nephrogenic DI is caused by medication (for example, lithium), stopping the medication may help restore normal kidney function. However, after many years of lithium use, the nephrogenic DI may be permanent. Hereditary nephrogenic DI and lithium-induced nephrogenic DI are treated by drinking enough fluids to match urine output and with drugs that lower urine output. Drugs used to treat nephrogenic DI include: Anti-inflammatory medication (indomethacin)and Diuretics (hydrochlorothiazide (HCTZ) and amiloride).



Johnfanisrour 19:14, 25 January 2009 (UTC) John Fani Srour Johnfanisrour 19:14, 25 January 2009 (UTC)

de:Polydipsie fi:Polydipsia lt:Troškulys nl:Polydipsie no:Polydipsi


Template:WH Template:WS